This antibody is purified through a protein A column, followed by peptide affinity purification.
Immunogen
This IFRD2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 478-506 amino acids from the C-terminal region of human IFRD2.
IFRD2
Reaktivität: Human
WB, ELISA
Wirt: Kaninchen
Polyclonal
unconjugated
Applikationshinweise
For WB starting dilution is: 1:1000
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
0.5 mg/mL
Buffer
Supplied in PBS with 0.09 % (W/V) sodium azide.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
4 °C,-20 °C
Informationen zur Lagerung
Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
IFRD2 contains a predicted bipartite nuclear localization signal and an armadillo-beta catenin-like repeat. It is highly expressed soon after gastrulation and in the hepatic primordium, suggesting an involvement in early hematopoiesis.